Phio Pharmaceuticals Corp. (PHIO)
1.17
-0.01
(-0.85%)
USD |
NASDAQ |
Aug 24, 16:00
1.15
-0.02
(-1.71%)
After-Hours: 20:00
Phio Pharmaceuticals Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2019 | 0.00% |
| December 31, 2018 | |
| September 30, 2018 | 0.00% |
| June 30, 2018 | 0.00% |
| March 31, 2018 | 0.00% |
| December 31, 2017 | 0.00% |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | 0.00% |
| March 31, 2016 | 0.00% |
| December 31, 2015 |
| Date | Value |
|---|---|
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | 0.00% |
| December 31, 2014 | 0.00% |
| September 30, 2014 | 0.00% |
| June 30, 2014 | 0.00% |
| March 31, 2014 | 0.00% |
| December 31, 2013 | 0.00% |
| September 30, 2013 | 0.00% |
| June 30, 2013 | 0.00% |
| March 31, 2013 | 0.00% |
| December 31, 2012 | 0.00% |
| September 30, 2012 | 0.00% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Imunon, Inc. | -- |
| Agenus, Inc. | 98.50% |
| Amgen, Inc. | 72.08% |
| Anika Therapeutics, Inc. | 65.15% |
| BioCryst Pharmaceuticals, Inc. | 98.01% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -93.31% |
| Return on Assets | -84.88% |
| Return on Invested Capital | -93.31% |
| Return on Net Operating Assets | -131.7K% |